Retatrutide Helped Adults With Obesity Lose Up to 30 Percent of Their Body Weight in New Trial
The experimental drug retatrutide just delivered some of the most impressive results to date for the newest generation of diabetes and obesity treatments known as GLP-1s, according to results published by the drugmaker Eli Lilly. [1] The findings suggest that, for people with obesity, retatrutide could offer more weight loss than any GLP-1 drug currently … Read more